Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Atripla

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Atripla was produced by Gilead Sciences.

GSK’s COPD drug Anoro under review in US

GSK’s COPD drug Anoro under review in US The FDA will review data from a phase III programme that demonstrated the integrase inhibitor was more effective than Gilead Sciences/Bristol-Myers Squibb's big-selling Atripla (efavirenz/emtricitabine/tenofovir

Shionogi: an expanding commercial focus

Shionogi: an expanding commercial focus In late-stage trials it recently beat Gilead's Atripla in a head-to-head study.

Gilead's triple HIV pill cleared in Europe

the market after Gilead, Bristol-Myers Squibb and Merck &Co's Atripla (efavirenz, tenofovir and emtricitabine). ... Atripla debuted in 2006 and has revenues of around $3bn a year with its convenience of treatment improving patient compliance.

Gilead Sciences in US investigation

The subpoena involves the drugs Atripla (efavirenz tenofovir emtricitabine), Emtriva (emtricitabine), Hepsera (adefovir dipivoxil), Letairis (ambrisentan), Truvada (tenofovir emtricitabine), Viread (tenofovir) and its investigational fixed-dose

Gilead EVP, Kevin Young, receives CBE

In the UK and Europe, Gilead is well known for Atripla (efavirenz tenofovir emtricitabine): its single tablet regimen (STR) for the treatment of HIV. ... Atripla is the only single tablet taken once a day that contains the triple-therapy required to

[ Previous 5 results ] 1 2 3 4 5 6 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

The other side of … rheumatoid arthritis
For Georgie, patient activation fuelled her motivation to find life without pain. So when blood tests came back normal, she felt confident to pursue referral until RA was confirmed......
How to lessen site burden with a targeted patient recruitment strategy
Picture this: you’ve created your patient recruitment strategy and you find more and more patients are undertaking the pre-screening, you probably think – success! But then you find out, getting...
Peter Howarth
Exploring the potential of eosinophils
GSK’s Peter Howarth talks about the emerging research that suggests there is a varied role for eosinophils...

Infographics